Money & Banking

Ayushman Bharat: 23,287 claims worth ₹38 crore approved in first ten days

Maitri Porecha New Delhi | Updated on October 02, 2018 Published on October 02, 2018 designer491

But hospitals find it difficult to log into the scheme portal; non-BJP States seek clarity



Ten days into its launch, the country’s most-ambitious health programme, Pradhan Mantri Jan Arogya Yojana – also known as Ayushman Bharat – has catered to more than 30,000 patients, with claims of ₹38.1 crore approved by the government in both public and private hospitals.

Claims approved

Up to 23,299 claims worth ₹45 crore have been submitted, of which 23,287 claims have been approved as on October 2.

Official data show that the average claim size per patient is ₹19,357.

As on date, 32,814 hospitals have applied for empanelment, of which 13,865 have been empanelled or are in the process of being empanelled. On October 1, Dinesh Arora, Deputy CEO of Ayushman Bharat, tweeted about a 67-year-old lady from Diglipur in North Andaman Islands, who was wheeled into government-run Govind Ballabh Pant Hospital at Port Blair with heavy bleeding.

She was diagnosed with cervix cancer. Sadly, people on the island, have no access to radiotherapy.

“She was flown into private-run MIOT hospital in Chennai and treated. Transportation costs were covered under the scheme,” said Arora.

However, 51-year-old labourer Prahlad Kumar, who had to travel 120 kilometers to non-profit Jan Swasthya Sahyog hospital in Bilaspur district of Chattisgarh, from neighbouring Kabirdham district, to seek treatment for stomach cancer, appears doubtful.

“I wonder if I will get the benefit of Ayushman Bharat for cancer treatment. We have very little money. Nobody in my village approached me to tell me about the new scheme,” said Prahlad.

No Ayush Mitra

Sushil Patil, medical co-ordinator at the hospital, informed BusinessLine that an ‘Ayush Mitra’ has not yet been appointed in the hospital by the government, despite the hospital being empanelled in the scheme.

“We are also facing issues logging into the scheme portal. We have prepared claims for close to 20 cancer patients who are waiting to be reimbursed, but we are facing hiccups with the scheme.

“Considering that the Chief Minister’s Health Scheme and previously-run Rashtriya Swasthya Bima Yojana have been discontinued and Ayushman Bharat is yet to start, the transition is not smooth and patients are left in the lurch,” said Patil.

Indu Bhushan, CEO of Ayushman Bharat, said: “We will ensure that the roll-out starts at the earliest in Jan Swasthya Sahyog. They are an important partner for us.”

Non-BJP States resist

While 31 States and Union Territories are on board, five States, all of which are not run by the BJP, are resisting from participating in the scheme, including Delhi (Aam Aadmi Party), Odisha (Biju Janta Dal), Punjab (Congress), Kerala (Left Democratic Front) and Telangana (Telangana Rashtra Samithi).

Kerala, which was massively affected by the recent floods, is refusing to join unless it gets more clarity on the scheme.

B Ekbal, Member, Kerala State Planning Board, said that the State had appointed a five-member committee to negotiate with the Central government.

“If the Ayushman Bharat is to be implemented, then the number of beneficiaries will come down from 41 lakh as they exist in Rashtriya Swasthya Bima Yojana (RSBY) at 21.5 lakh.

“We currently give treatment under 1,785 disease packages, but in Ayushman, there are only 1,350 packages. There is no clear indication towards the premium to be paid by the Central government. Whatever it is, this will result in a tremendous burden for the State government,” said Ekbal.

Published on October 02, 2018

A letter from the Editor

Dear Readers,

The coronavirus crisis has changed the world completely in the last few months. All of us have been locked into our homes, economic activity has come to a near standstill. Everyone has been impacted.

Including your favourite business and financial newspaper. Our printing and distribution chains have been severely disrupted across the country, leaving readers without access to newspapers. Newspaper delivery agents have also been unable to service their customers because of multiple restrictions.

In these difficult times, we, at BusinessLine have been working continuously every day so that you are informed about all the developments – whether on the pandemic, on policy responses, or the impact on the world of business and finance. Our team has been working round the clock to keep track of developments so that you – the reader – gets accurate information and actionable insights so that you can protect your jobs, businesses, finances and investments.

We are trying our best to ensure the newspaper reaches your hands every day. We have also ensured that even if your paper is not delivered, you can access BusinessLine in the e-paper format – just as it appears in print. Our website and apps too, are updated every minute, so that you can access the information you want anywhere, anytime.

But all this comes at a heavy cost. As you are aware, the lockdowns have wiped out almost all our entire revenue stream. Sustaining our quality journalism has become extremely challenging. That we have managed so far is thanks to your support. I thank all our subscribers – print and digital – for your support.

I appeal to all or readers to help us navigate these challenging times and help sustain one of the truly independent and credible voices in the world of Indian journalism. Doing so is easy. You can help us enormously simply by subscribing to our digital or e-paper editions. We offer several affordable subscription plans for our website, which includes Portfolio, our investment advisory section that offers rich investment advice from our highly qualified, in-house Research Bureau, the only such team in the Indian newspaper industry.

A little help from you can make a huge difference to the cause of quality journalism!

Support Quality Journalism
This article is closed for comments.
Please Email the Editor
You have read 1 out of 3 free articles for this week. For full access, please subscribe and get unlimited access to all sections.